In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.
A recent study by the ICMR National Centre for Disease Informatics and Research warns of a 5.6% annual increase in Indian breast cancer cases, driven by various risk factors.
Menopausal hormone therapy (MHT) does not raise breast cancer risk in women with breast cancer gene mutations, while estrogen only MHT leads to reduced risk.
Use of menopausal hormone therapy following menopause is not associated with increased risk for breast cancer among BRCA1 and BRCA2 carriers.
Parade on MSN
Angelina Jolie Reveals Mastectomy Scars for the First Time: ‘I Share These Scars With Many Women I Love'
Angelina Jolie is revealing her mastectomy scars in a new interview in an effort to encourage women to take breast health seriously.
Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited mutations in the BRCA1 or BRCA2 genes, according to the results of a matched ...
Woman's World on MSN
Could you be eligible for a promising breast cancer vaccine trial?
Odds are you know someone who has had breast cancer, or maybe you're even a survivor yourself. But what if we told you there ...
Holiday family gatherings offer a great opportunity to create valuable new memories with our loved ones, and to share ...
Much like finding a single sock missing after laundry day, it is easy for men to overlook the possibility of breast cancer, ...
Angelina Jolie revealed why she wanted to share her mastectomy scars more than a decade after the procedure: “I’m always moved when I see other women share theirs.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results